biointo.co.kr

What It Is

BIO INTO（바이오인투） is a professional translation company in South Korea, positioned around vertical fields such as pharmaceuticals, clinical research, medicine, pharmacy, medical devices, as well as economics and finance. Based on the information on its website, it is not a typical SaaS or enterprise software platform, but rather a language service provider centered on professional human translation, native-speaker proofreading, and project management.

Core Features and Workflow

Its services cover documents such as clinical trial protocols, clinical trial/research reports, informed consent forms, medical and pharmaceutical manuals, academic papers, as well as audit reports, investment outlooks, accounting procedures, budget sheets, and balance sheets. The workflow described on the website is fairly traditional: translation files are first confirmed, then a quotation and contract are prepared, after which a person in charge is assigned and translation begins. The company emphasizes working with professional translators and native proofreaders with more than 10 years of relevant experience, managed by a PM. This can be valuable for terminology consistency and accurate expression in medical and clinical documents.

Pricing and Enterprise Software Capabilities

In terms of pricing, the website does not publish packages, unit prices, per-word rates, rush fees, or minimum order amounts. It only provides phone and email channels for inquiries, so procurement requires manual communication in advance. From a SaaS perspective, the text does not mention online ordering, project dashboards, customer portals, permission management, translation memory, terminology databases, APIs, third-party system integrations, or self-hosted deployment. Therefore, it should not be regarded as a platform with full enterprise software capabilities.

Pros and Cons

Its strengths are a clear industry focus, making it especially suitable for highly specialized documents in pharmaceuticals, clinical research, medicine, and pharmacy. It also publicly lists contact details, business hours, and a company address in South Korea, giving businesses a clear path for communication. The downsides are limited transparency: there are no clear pricing standards, delivery timelines, supported languages, quality certifications, confidentiality measures, or compliance statements. It also discloses relatively little about audit, permission, and data security requirements commonly expected by multinational enterprises.

Who It’s For and Access from China

It is better suited to pharmaceutical companies, CROs, medical device companies, or financial institutions that need Korean-related professional human translation and are willing to request quotes by email or phone. Access from mainland China cannot be determined from the available text alone, and payment methods are not disclosed. If you need local invoices, RMB payment, online collaboration, or large-scale API translation, alternatives may include local Chinese medical translation providers, CRO-supported translation services, or enterprise-grade translation management platforms.